Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. COMBIVIR (N/R/ lamivudine/ zidovudine/ lamivudine et zidovudine)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

COMBIVIR (N/R/ lamivudine/ zidovudine/ lamivudine et zidovudine)

Medicine - Posted on Jun 29 2017 - Updated on Jun 12 2019
Active substance (DCI)
  • lamivudine
  • zidovudine
history (5)
  • 6/21/17

    COMBIVIR (lamivudine/ zidovudine)

    Maintien du remboursement dans les mêmes conditions
    icône flèche
  • 5/23/12

    COMBIVIR (lamivudine/ zidovudine)

    COMBIVIR (lamivudine/ zidovudine)
    icône flèche
  • 4/29/09

    COMBIVIR

    Alternative à l’association des deux spécialités sous forme de solution buvable, chez les enfants infectés par le VIH pesant...
    CAV :
    54321
    icône flèche
  • 1/23/08

    COMBIVIR (lamivudine/ zidovudine)

    COMBIVIR (lamivudine/ zidovudine)
    icône flèche
  • 10/2/02

    COMBIVIR (lamivudine/ zidovudine)

    COMBIVIR (lamivudine/ zidovudine)
    icône flèche
Technical information
ATC code
  • J05AR01
  • J05AF30
Manufacturer
GLAXOSMITHKLINE/ ViiV HEALTHCARE SAS
Presentation

COMBIVIR 150 mg/300 mg, comprimé pelliculé (code CIS : 65521773)
6 plaquette(s) thermoformée(s) PVC de 10 comprimé(s) - (Code CIP : 34009 346 627 1 3)

All our publications
    Drug therapy Immunologic deficiency syndromes Paediatrics Sexually transmitted diseases Virus diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
cRDrFTvKSJCu1a5Z